CareDx, Inc.
$53.55
$0.91 (+1.73%)
$52.61Day Range$54.49
Key Statistics
Market Cap
$2.77B
Shares Outstanding
51.7M
Primary Exchange
XNAS
Currency
USD
Type
CS
IPO Date
Jul 17, 2014
Round Lot
100
Locale
US
Trading Data
Day Open
$52.61
Day High
$54.49
Day Low
$52.61
Volume
846.3K
VWAP
$53.60
Prev Close
$52.64
Transactions
--
Acc. Volume
--
About CareDx, Inc.
CareDx Inc operates as a precision medicine company focused on the discovery, development, and commercialization of clinically differentiated, high-value healthcare solutions for transplant patients and caregivers. It offers testing services, products, and digital solutions along with the pre- and post-transplant patient journey and is a provider of genomics-based information for transplant patients. The Company's commercially available testing services consist of AlloSure Kidney, AlloMap Heart, AlloSure Heart, a dd-cfDNA solution for heart transplant patients, and AlloSure Lung, a dd-cfDNA solution for lung transplant patients. Geographically it generates the majority of its revenue from the United States. The company generates the majority of revenue from the Testing services.
SERVICES-MEDICAL LABORATORIESSIC 8071765 employees8000 MARINA BLVD, BRISBANE, CA, 94005415-287-2300IPO Jul 17, 2014US / STOCKSActiveWebsite
Identifiers
- CIK
- 0001217234
- Composite FIGI
- BBG006JS5785
- Share Class FIGI
- BBG006JS5794
- Ticker Root
- CDNA
- SIC Code
- 8071
About CareDx, Inc. (CDNA) Stock
CareDx, Inc. (CDNA) closed the 2026-09-16 session at $53.55, up 1.73% versus the previous close (+0.91). The stock opened at $52.61 and traded between $52.61 and $54.49 during that session. Session trading volume was 846K shares. The volume-weighted average price (VWAP) is $53.60.
CareDx Inc operates as a precision medicine company focused on the discovery, development, and commercialization of clinically differentiated, high-value healthcare solutions for transplant patients and caregivers. It offers testing services, products, and digital solutions along with the pre- and post-transplant patient journey and is a provider of genomics-based information for transplant patients. The Company's commercially available testing services consist of AlloSure Kidney, AlloMap Heart, AlloSure Heart, a dd-cfDNA solution for heart transplant patients, and AlloSure Lung, a dd-cfDNA solution for lung transplant patients. Geographically it generates the majority of its revenue from the United States. The company generates the majority of revenue from the Testing services.
CareDx, Inc. has a market capitalization of $2.77 billion. The company operates in the SERVICES-MEDICAL LABORATORIES industry classification. CDNA is listed on the XNAS exchange. The company employs approximately 765 people. CareDx, Inc. is headquartered in BRISBANE, CA. The recorded listing date is 2014-07-17.
On this page you can find market CDNA stock price data, interactive price charts with multiple timeframes (1 day to max history), company financials including income statements, balance sheets, and cash flow statements, technical indicators (SMA 50, SMA 200, EMA 20, MACD, RSI), latest news and sentiment analysis, dividend history, stock splits, short interest data, float information, and related stocks.
Explore more: View today's market movers, use the stock screener, or browse all sectors. See more stocks in the SERVICES-MEDICAL LABORATORIES sector.